(Q50555256)

15 March 2018

title

The effect of a clinically effective and non-effective dose of lorazepam on 7.5% CO₂-induced anxiety. (English)

1 reference

15 March 2018

1 reference

Jayne E Bailey

7

0 references

David Nutt

object named as

David J Nutt

6

0 references

Colin T Dourish

object named as

Colin T Dourish

5

0 references

author name string

Alison Diaper

1

1 reference

15 March 2018

Andreas Papadopoulos

2

1 reference

15 March 2018

Ann S Rich

3

1 reference

15 March 2018

Gerry R Dawson

4

1 reference

15 March 2018

publication date

2 October 2012

1 reference

15 March 2018

published in

Human Psychopharmacology

1 reference

15 March 2018

volume

27

1 reference

15 March 2018

page(s)

540-548

1 reference

15 March 2018

issue

6

1 reference

15 March 2018

Inhalation of 35% CO(2) results in activation of the HPA axis in healthy volunteers

cites work

1 reference

Subtype-selective GABA(A) receptor modulation yields a novel pharmacological profile: the design and development of TPA023.

21 January 2018

1 reference

GABA-A receptors and the response to CO(2) inhalation - a translational trans-species model of anxiety?

21 January 2018

1 reference

Behavioral and cardiovascular effects of 7.5% CO2 in human volunteers.

21 January 2018

1 reference

Does the Brain Noradrenaline Network Mediate the Effects of the CO2 Challenge?

21 January 2018

1 reference

Validating the inhalation of 7.5% CO(2) in healthy volunteers as a human experimental medicine: a model of generalized anxiety disorder (GAD).

21 January 2018

1 reference

A validation of the 7.5% CO2 model of GAD using paroxetine and lorazepam in healthy volunteers

21 January 2018

1 reference

Preliminary evidence of anxiolytic effects of the CRF(1) receptor antagonist R317573 in the 7.5% CO(2) proof-of-concept experimental model of human anxiety.

21 January 2018

1 reference

A comparison of the effects of a subtype selective and non-selective benzodiazepine receptor agonist in two CO(2) models of experimental human anxiety.

21 January 2018

1 reference

21 January 2018

1 reference

Does 5-HT restrain panic? A tryptophan depletion study in panic disorder patients recovered on paroxetine

21 January 2018

1 reference

GABAergic and dopaminergic transmission in the rat cerebral cortex: effect of stress, anxiolytic and anxiogenic drugs

21 January 2018

1 reference

SPECT [I-123]iomazenil measurement of the benzodiazepine receptor in panic disorder

21 January 2018

1 reference

Carbon dioxide inhalation, stress and anxiogenic drugs reduce the function of GABAA receptor complex in the rat brain.

21 January 2018

1 reference

Brain circuits in panic disorder

21 January 2018

1 reference

GABAmimetic agents display anxiolytic-like effects in the social interaction and elevated plus maze procedures

21 January 2018

1 reference

Evaluation of the effects of venlafaxine and pregabalin on the carbon dioxide inhalation models of Generalised Anxiety Disorder and panic.

21 January 2018

1 reference

CO2 challenge results in hypothalamic-pituitary-adrenal activation in healthy volunteers

21 January 2018

1 reference

Absence of food effect on the extent of alprazolam absorption from an orally disintegrating tablet.

21 January 2018

1 reference

Ventilatory physiology of patients with panic disorder.

21 January 2018

1 reference

Neuroanatomical hypothesis of panic disorder, revised

21 January 2018

1 reference

Effects of lorazepam on fear-potentiated startle responses in man.

21 January 2018

1 reference

Comparative single-dose kinetics and dynamics of lorazepam, alprazolam, prazepam, and placebo

21 January 2018

1 reference

Effect of acute antidepressant administration on negative affective bias in depressed patients

21 January 2018

1 reference

Provocation of panic: three elements of the panic reaction in four anxiety disorders.

21 January 2018

1 reference

Acute carbon dioxide exposure in healthy adults: evaluation of a novel means of investigating the stress response.

21 January 2018

1 reference

False suffocation alarms, spontaneous panics, and related conditions. An integrative hypothesis

21 January 2018

1 reference

Decreased brain GABA(A)-benzodiazepine receptor binding in panic disorder: preliminary results from a quantitative PET study.

21 January 2018

1 reference

Psychotropic medication consumption patterns in the UK general population.

21 January 2018

1 reference

The effects of single dose anxiolytic medication on the CO2 models of anxiety: differentiation of subjective and objective measures.

21 January 2018

1 reference

Modulation of hyperreactivity to 35% CO2 after one week of treatment with paroxetine and reboxetine: a double-blind, randomized study

21 January 2018

1 reference

Antipanic drug modulation of 35% CO2 hyperreactivity and short-term treatment outcome

21 January 2018

1 reference

Characterization of a 7% carbon dioxide (CO2) inhalation paradigm to evoke anxiety symptoms in healthy subjects.

21 January 2018

1 reference

Anxiety sensitivity, anxiety frequency and the prediction of fearfulness

21 January 2018

1 reference

The influence of an illusion of control on panic attacks induced via inhalation of 5.5% carbon dioxide-enriched air.

21 January 2018

1 reference

Carbon dioxide inhalation reduces the function of GABAA receptors in the rat brain

21 January 2018

1 reference

Effects of lorazepam on brain activity pattern during an anxiety symptom provocation challenge.

21 January 2018

1 reference

Effects of 7.5% CO2 challenge in generalized anxiety disorder.

21 January 2018

1 reference

Cerebral benzodiazepine receptor binding and distribution in generalized anxiety disorder: a fractal analysis.

21 January 2018

1 reference

Hypercapnia-induced activation of brainstem GABAergic neurons during early development

21 January 2018

1 reference

The amygdala is a chemosensor that detects carbon dioxide and acidosis to elicit fear behavior.

21 January 2018

1 reference

The effects of clonidine on cardiovascular responses to standing in healthy volunteers

21 January 2018

1 reference

The 35% CO2 challenge in panic disorder: Optimization by receiver operating characteristic (ROC) analysis

21 January 2018

1 reference

7 January 2021

Effects of a safe person on induced distress following a biological challenge in panic disorder with agoraphobia

1 reference

7 January 2021

The effects of hyperventilation; individual variability and its relation to personality

1 reference

7 January 2021

Effect of antipanic treatment on response to carbon dioxide

1 reference

7 January 2021

Buspirone and lorazepam in the treatment of generalized anxiety disorder in outpatients

1 reference

7 January 2021

Flumazenil provocation of panic attacks. Evidence for altered benzodiazepine receptor sensitivity in panic disorder

1 reference

7 January 2021

Identifiers

DOI

10.1002/HUP.2261

1 reference

15 March 2018

release_6e3uimpycfd4dmbfnnkvw5ukvu

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/6e3uimpycfd4dmbfnnkvw5ukvu

24 November 2022

mapped directly with Wikidata item

PubMed ID

23027657

1 reference

15 March 2018